Risk for hospital readmission following bariatric surgery

Robert B Dorman, Christopher J Miller, Daniel B Leslie, Federico J Serrot, Bridget Slusarek, Henry Buchwald, John E Connett, Sayeed Ikramuddin, Robert B Dorman, Christopher J Miller, Daniel B Leslie, Federico J Serrot, Bridget Slusarek, Henry Buchwald, John E Connett, Sayeed Ikramuddin

Abstract

Background and objectives: Complications resulting in hospital readmission are important concerns for those considering bariatric surgery, yet present understanding of the risk for these events is limited to a small number of patient factors. We sought to identify demographic characteristics, concomitant morbidities, and perioperative factors associated with hospital readmission following bariatric surgery.

Methods: We report on a prospective observational study of 24,662 patients undergoing primary RYGB and 26,002 patients undergoing primary AGB at 249 and 317 Bariatric Surgery Centers of Excellence (BSCOE), respectively, in the United States from January 2007 to August 2009. Data were collected using standardized assessments of demographic factors and comorbidities, as well as longitudinal records of hospital readmissions, complications, and mortality.

Results: The readmission rate was 5.8% for RYGB and 1.2% for AGB patients 30 days after discharge. The greatest predictors for readmission following RYGB were prolonged length of stay (adjusted odds ratio [OR], 2.3; 95% confidence interval [CI], 2.0-2.7), open surgery (OR, 1.8; CI, 1.4-2.2), and pseudotumor cerebri (OR, 1.6; CI, 1.1-2.4). Prolonged length of stay (OR, 2.3; CI, 1.6-3.3), history of deep venous thrombosis or pulmonary embolism (OR, 2.1; CI, 1.3-3.3), asthma (OR, 1.5; CI, 1.1-2.1), and obstructive sleep apnea (OR, 1.5; CI, 1.1-1.9) were associated with the greatest increases in readmission risk for AGB. The 30-day mortality rate was 0.14% for RYGB and 0.02% for AGB.

Conclusion: Readmission rates are low and mortality is very rare following bariatric surgery, but risk for both is significantly higher after RYGB. Predictors of readmission were disparate for the two procedures. Results do not support excluding patients with certain comorbidities since any reductions in overall readmission rates would be very small on the absolute risk scale. Future research should evaluate the efficacy of post-surgical managed care plans for patients at higher risk for readmission and adverse events.

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1. Flow diagram of patient selection.
Figure 1. Flow diagram of patient selection.
Figure 2. Cumulative incidence of 30-day readmission…
Figure 2. Cumulative incidence of 30-day readmission by surgery.
Figure 3. Loess plot of RYGB readmission…
Figure 3. Loess plot of RYGB readmission rates on follow-up rates.
Circles represent BSCOE hospitals with the size weighted by the number of patients who underwent the procedure in the hospital during the study period.
Figure 4. Loess plot of AGB readmission…
Figure 4. Loess plot of AGB readmission rates on follow-up rates.
Circles represent BSCOE hospitals with the size weighted by the number of patients who underwent the procedure in the hospital during the study period.

References

    1. Santry HP, Gillen DL, Lauderdale DS. Trends in bariatric surgical procedures. JAMA. 2005;294:1909–1917.
    1. American Society for Metabolic and Bariatric Surgery, Metabolic & Bariatric Surgery Fact Sheet. Final report May 2011. Gainesville, FL: Media Press Kit; 2011. Available: . Accessed 2011 August 25.
    1. Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292:1724–1737.
    1. Dorman RB, Abraham AA, Al-Refaie WB, Parsons HM, Ikramuddin S, et al. Bariatric Surgery Outcomes in the Elderly Population: An ACS NISQIP Study. J Gastrointest Surg. 2011;16:35–44.
    1. Flum DR, Belle SH, King WC, Wahed AS, Berk P, et al. Perioperative safety in the longitudinal assessment of bariatric surgery. NEJM. 2009;361:445–454.
    1. Zingmond DS, McGory ML, Ko CY. Hospitalization before and after gastric bypass surgery. JAMA. 2005;294:1918–1924.
    1. Encinosa WE, Bernard DM, Chen CC, Steiner CA. Healthcare utilization and outcomes after bariatric surgery. Med Care. 2006;44:706–712.
    1. DeMaria EJ, Pate V, Warthen M, Winegar DA. Baseline data from American Society for Metabolic and Bariatric Surgery-designated Bariatric Surgery Centers of Excellence using the Bariatric Outcomes Longitudinal Database. Surg Obes Relat Dis. 2010;6:347–355.
    1. Adams TD, Gress RE, Smith SC, Halverson RC, Simper SC, et al. Long-term mortality after gastric bypass surgery. NEJM. 2007;357:753–761.
    1. Buchwald H, Estok R, Fahrbach K, Banel D, Jensen MD, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med. 2009;122:248–256.
    1. Dorman RB, Serrot FJ, Miller CJ, Slusarek B, Sampson B, et al. Case-matched outcomes in bariatric surgery for the treatment of type 2 diabetes in the morbidly obese patient. Ann Surg. 2012;255:287–293.
    1. Pories WJ, MacDonald KG, Morgan EJ, Sinha MK, Dohm GL, et al. Surgical treatment of obesity and its effect on diabetes: 10-y follow-up. Am J Clin Nutr. 1992;55:582S–585S.
    1. Sjostrom L, Lindroos AK, Peltonen M, Torgerson J, Bouchard C, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. NEJM. 2004;351:2683–2693.
    1. Sjostrom L, Narbro K, Sjostrom CD, Karason K, Larsson B, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. NEJM. 2007;357:741–752.
    1. Vetter ML, Cardillo S, Rickels MR, Iqbal N. Narrative review: effect of bariatric surgery on type 2 diabetes mellitus. Ann Intern Med. 2009;150:94–103.
    1. Birkmeyer NJ, Dimick JB, Share D, Hawasli A, English WJ, et al. Hospital complication rates with bariatric surgery in Michigan. JAMA. 2010;304:435–442.
    1. Kellogg TA, Swan T, Leslie DA, Buchwald H, Ikramuddin S. Patterns of readmission and reoperation within 90 days after Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2009;5:416–423.
    1. Saunders J, Ballantyne GH, Belsley S, Stephens DJ, Trivedi A, et al. One-year readmission rates at a high volume bariatric surgery center: laparoscopic adjustable gastric banding, laparoscopic gastric bypass, and vertical banded gastroplasty-Roux-en-Y gastric bypass. Obes Surg. 2008;18:1233–1240.
    1. Weller WE, Hannan EL. Relationship between provider volume and postoperative complications for bariatric procedures in New York State. J Am Coll Surg. 2006;202:753–761.
    1. Weller WE, Rosati C, Hannan EL. Relationship between surgeon and hospital volume and readmission after bariatric operation. J Am Coll Surg. 2007;204:383–391.
    1. Nguyen NT, Slone JA, Nguyen XM, Hartman JS, Hoyt DB. A prospective randomized trial of laparoscopic gastric bypass versus laparoscopic adjustable gastric banding for the treatment of morbid obesity: outcomes, quality of life, and costs. Ann Surg. 2009;250:631–641.
    1. Weber M, Muller MK, Bucher T, Wildi S, Dindo D, et al. Laparoscopic gastric bypass is superior to laparoscopic gastric banding for treatment of morbid obesity. Ann Surg. 2004;240:975–982. discussion 982-973.
    1. Maggard MA, Shugarman LR, Suttorp M, Maglione M, Sugerman HJ, et al. Meta-analysis: surgical treatment of obesity. Ann Intern Med. 2005;142:547–559.
    1. Puzziferri N, Austrheim-Smith IT, Wolfe BM, Wilson SE, Nguyen NT. Three-year follow-up of a prospective randomized trial comparing laparoscopic versus open gastric bypass. Ann Surg. 2006;243:181–188.
    1. Hutter MM, Randall S, Khuri SF, Henderson WG, Abbott WM, et al. Laparoscopic versus open gastric bypass for morbid obesity: a multicenter, prospective, risk-adjusted analysis from the National Surgical Quality Improvement Program. Ann Surg. 2006;243:657–662.
    1. Gupta PK, Franck C, Miller WJ, Gupta H, Forse RA. Development and validation of a bariatric surgery morbidity risk calculator using the prospective, multicenter NSQIP dataset. J Am Coll Surg. 2011;212:301–309.

Source: PubMed

3
Abonneren